Pharmacogenomics positively impacts polypharmacy-related toxicity and clinical outcomes in psychiatric patients.

Pandi MT, Koufaki MI, Skokou M, Selzer D, Mitropoulou C, Lehr T, Patrinos GP

Open source

DOI
10.1016/j.phrs.2026.109735
Published
2026 Nov 5
Container
Pharmacological research
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.phrs.2026.109735,
  title = {Pharmacogenomics positively impacts polypharmacy-related toxicity and clinical outcomes in psychiatric patients.},
  author = {Pandi MT and Koufaki MI and Skokou M and Selzer D and Mitropoulou C and Lehr T and Patrinos GP},
  year = {2026},
  journal = {Pharmacological research},
  doi = {10.1016/j.phrs.2026.109735},
  url = {https://doi.org/10.1016/j.phrs.2026.109735}
}

RIS

TY  - JOUR
TI  - Pharmacogenomics positively impacts polypharmacy-related toxicity and clinical outcomes in psychiatric patients.
AU  - Pandi MT
AU  - Koufaki MI
AU  - Skokou M
AU  - Selzer D
AU  - Mitropoulou C
AU  - Lehr T
AU  - Patrinos GP
PY  - 2026
JO  - Pharmacological research
DO  - 10.1016/j.phrs.2026.109735
UR  - https://doi.org/10.1016/j.phrs.2026.109735
ER  - 

APA

MT, P., MI, K., M, S., D, S., C, M., T, L., & GP, P. (2026). Pharmacogenomics positively impacts polypharmacy-related toxicity and clinical outcomes in psychiatric patients.. Pharmacological research. https://doi.org/10.1016/j.phrs.2026.109735

Source records